beta-Interferon regulates the immunomodulatory activity of neonatal rodent microglia (Q72997019)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

beta-Interferon regulates the immunomodulatory activity of neonatal rodent microglia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

G L Hall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M G Wing

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D A Compston

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

N J Scolding

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

11-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Macrophage activation by interferon alpha + beta is associated with a loss of proliferative capacity: role of interferon alpha + beta in the regulation of macrophage proliferation and function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Multiple sclerosis: a pivotal role for the T cell in lesion development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Induction of primary T cell responses by human glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Microglia present myelin antigens to T cells after phagocytosis of oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Characterization of ameboid microglia isolated from developing mammalian brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Cytostasis of different tumours by a murine PPD-reactive CD4+ T lymphocyte clone is mediated by interferon-gamma and tumour necrosis factor alone or synergistically

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Functional antagonism between type I and type II interferons on human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Demonstration of alpha, beta, and gamma interferon in active chronic multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Does interferon beta cause initial exacerbation of multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Interferon beta augments suppressor cell function in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900128-2

7 January 2021

10.1016/S0165-5728(96)00128-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003241%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference